Inflazome
Signals that cause immune cells to fight infections
Total raised
€56M
€56,015,308
Funding rounds
3
Investors
4
distinct backers
Active since
2016-08
latest 2018-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood9
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 10y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Other | €860k | Michael J. Fox Foundation | View deal → |
| 2018-11-19 | Series B | €40M | Forbion Capital Partners | View deal → |
| 2016-09-01 | Series A | €15M | Fountain Healthcare Partners,Novartis Venture Fund | View deal → |
Investors
4Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech